Cargando…
The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
CRNDE, recently described as the lncRNA-coding gene, is overexpressed at RNA level in human malignancies. Its role in gametogenesis, cellular differentiation and pluripotency has been suggested as well. Herein, we aimed to verify our hypothesis that the CRNDE gene may encode a protein product, CRNDE...
Autores principales: | Szafron, Lukasz Michal, Balcerak, Anna, Grzybowska, Ewa Anna, Pienkowska-Grela, Barbara, Felisiak-Golabek, Anna, Podgorska, Agnieszka, Kulesza, Magdalena, Nowak, Natalia, Pomorski, Pawel, Wysocki, Juliusz, Rubel, Tymon, Dansonka-Mieszkowska, Agnieszka, Konopka, Bozena, Lukasik, Martyna, Kupryjanczyk, Jolanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433331/ https://www.ncbi.nlm.nih.gov/pubmed/25978564 http://dx.doi.org/10.1371/journal.pone.0127475 |
Ejemplares similares
-
The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015) -
The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
por: Konopka, Bozena, et al.
Publicado: (2016) -
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018) -
PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2022) -
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015)